,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Abdominal distension,6,16209451
0,22.0,Fracture,6,16209457
0,22.0,Acute kidney injury,5,16209458
0,22.1,Blood lactate dehydrogenase increased,1,16209459
1,22.1,Gamma-glutamyltransferase increased,6,16209459
2,22.1,Aspartate aminotransferase increased,1,16209459
3,22.1,Alanine aminotransferase increased,1,16209459
4,22.1,Diarrhoea,2,16209459
0,22.0,Diarrhoea,1,16209460
1,22.0,Back pain,1,16209460
0,22.0,Muscle contractions involuntary,3,16209461
1,22.0,Asthenia,3,16209461
2,22.0,Hyporeflexia,3,16209461
3,22.0,Paraesthesia,3,16209461
4,22.0,Dermatitis acneiform,3,16209461
0,22.0,Insomnia,6,16209462
1,22.0,Fatigue,3,16209462
2,22.0,Cough,3,16209462
3,22.0,Conjunctivitis,1,16209462
4,22.0,Nasopharyngitis,1,16209462
5,22.0,Bone marrow failure,1,16209462
6,22.0,Sluggishness,6,16209462
0,22.0,Gastroenteritis,1,16209469
0,22.0,Hyporeflexia,3,16209486
1,22.0,Paraesthesia,3,16209486
2,22.0,Asthenia,3,16209486
3,22.0,Dermatitis acneiform,3,16209486
4,22.0,Muscle contractions involuntary,3,16209486
0,22.1,Vomiting,6,16209492
1,22.1,Nausea,6,16209492
2,22.1,Blood count abnormal,2,16209492
3,22.1,Dysuria,6,16209492
4,22.1,Diarrhoea,6,16209492
0,22.0,Fatigue,6,16209496
0,22.0,Neoplasm progression,6,16209497
0,22.1,Fatigue,6,16209502
1,22.1,Alopecia,6,16209502
2,22.1,Nausea,6,16209502
3,22.1,Malaise,6,16209502
0,22.0,Generalised oedema,2,16209525
0,22.0,Renal artery thrombosis,1,16209538
0,22.0,Pleural effusion,6,16209552
1,22.0,Anal haemorrhage,1,16209552
0,22.0,Pain,6,16209577
1,22.0,Emotional distress,6,16209577
2,22.0,Anxiety,6,16209577
3,22.0,Psychological trauma,6,16209577
4,22.0,Alopecia,2,16209577
5,22.0,Impaired quality of life,6,16209577
0,22.0,Alopecia,2,16209579
0,22.0,Pneumonia,6,16209601
1,22.0,Pseudomonas infection,6,16209601
2,22.0,Fungal infection,6,16209601
3,22.0,Interstitial lung disease,3,16209601
4,22.0,Interstitial lung disease,2,16209601
5,22.0,Pneumonia,5,16209601
0,22.1,Serotonin syndrome,1,16209620
1,22.1,Nausea,6,16209620
2,22.1,Drug interaction,1,16209620
3,22.1,Tachycardia,6,16209620
4,22.1,Akathisia,6,16209620
5,22.1,Dizziness,6,16209620
6,22.1,Hyperhidrosis,6,16209620
7,22.1,Insomnia,6,16209620
0,22.0,Drug hypersensitivity,1,16209637
1,22.0,Chills,1,16209637
2,22.0,Erythema,1,16209637
3,22.0,Rash pustular,1,16209637
0,22.1,Haematochezia,6,16209764
1,22.1,Neoplasm progression,6,16209764
2,22.1,Mucous stools,3,16209764
3,22.1,Pneumonitis,6,16209764
4,22.1,Hepatomegaly,6,16209764
5,22.1,Haematochezia,1,16209764
6,22.1,Epistaxis,6,16209764
7,22.1,Platelet count decreased,6,16209764
8,22.1,Contusion,6,16209764
9,22.1,Gait disturbance,6,16209764
10,22.1,Carbohydrate antigen 15-3 increased,6,16209764
11,22.1,Stomatitis,6,16209764
0,22.0,Osteonecrosis,3,16209805
0,22.0,Prostate cancer metastatic,6,16209898
1,22.0,Agitation,6,16209898
2,22.0,Delirium,6,16209898
3,22.0,Altered state of consciousness,6,16209898
4,22.0,Hydronephrosis,6,16209898
5,22.0,Acute kidney injury,1,16209898
6,22.0,Muscle spasticity,1,16209898
7,22.0,Scrotal oedema,2,16209898
8,22.0,Cellulitis,6,16209898
9,22.0,Blood bicarbonate abnormal,6,16209898
10,22.0,White blood cell count decreased,6,16209898
11,22.0,Haemoglobin decreased,6,16209898
12,22.0,Bladder wall calcification,6,16209898
13,22.0,Ureteric obstruction,6,16209898
14,22.0,Scrotal erythema,2,16209898
15,22.0,Oedema peripheral,2,16209898
0,22.0,Death,5,16209922
0,22.0,Emergency care,1,16209933
1,22.0,Hot flush,3,16209933
2,22.0,Hyperhidrosis,6,16209933
3,22.0,Feeling cold,3,16209933
4,22.0,Hypoaesthesia,3,16209933
5,22.0,Unevaluable event,3,16209933
6,22.0,Oedema,3,16209933
0,22.1,Skin ulcer,2,16209993
1,22.1,Extremity necrosis,2,16209993
0,22.0,Colitis,6,16210008
1,22.0,Hypophysitis,6,16210008
2,22.0,Hypoglycaemia,6,16210008
3,22.0,Eczema,6,16210008
4,22.0,Anal abscess,6,16210008
5,22.0,Clostridium difficile colitis,6,16210008
6,22.0,Toxicity to various agents,6,16210008
7,22.0,Skin ulcer,6,16210008
8,22.0,Oedema peripheral,6,16210008
9,22.0,Skin disorder,6,16210008
0,22.1,Metastasis,6,16210039
1,22.1,Ascites,6,16210039
2,22.1,Abdominal distension,6,16210039
3,22.1,Food intolerance,6,16210039
4,22.1,Breast cancer recurrent,6,16210039
5,22.1,Vomiting,6,16210039
0,22.0,Death,5,16210048
0,22.0,Lactic acidosis,1,16210073
1,22.0,Dyspnoea,1,16210073
2,22.0,Acute kidney injury,1,16210073
0,22.0,Rash,3,16210077
1,22.0,Rash pruritic,3,16210077
2,22.0,White blood cell count decreased,3,16210077
3,22.0,Pyrexia,3,16210077
0,22.0,Influenza,1,16210081
1,22.0,Haematuria,1,16210081
2,22.0,White blood cell count decreased,6,16210081
3,22.0,Anaemia,6,16210081
4,22.0,Oropharyngeal pain,6,16210081
5,22.0,Cough,2,16210081
6,22.0,Neutropenia,6,16210081
7,22.0,Chest pain,1,16210081
8,22.0,Constipation,6,16210081
9,22.0,Pancytopenia,6,16210081
10,22.0,Sepsis,6,16210081
11,22.0,Petechiae,2,16210081
12,22.0,Thrombocytopenia,1,16210081
13,22.0,Dizziness,3,16210081
0,22.0,Metastases to central nervous system,3,16210084
1,22.0,Malignant neoplasm progression,6,16210084
0,22.0,Product use in unapproved indication,6,16210094
1,22.0,Fatigue,3,16210094
2,22.0,Gastric ulcer,1,16210094
3,22.0,Arthralgia,3,16210094
0,22.0,Haematotoxicity,6,16210198
0,22.0,Maternal exposure during pregnancy,6,16210211
1,22.0,Breast cancer recurrent,5,16210211
0,22.0,Off label use,6,16210215
1,22.0,Intentional product use issue,6,16210215
2,22.0,Artificial menopause,6,16210215
3,22.0,Metastases to lung,6,16210215
0,22.0,Amaurosis,3,16210264
1,22.0,Visual field defect,3,16210264
2,22.0,Optic neuritis,3,16210264
3,22.0,Visual impairment,3,16210264
0,22.0,Ascites,6,16210329
0,22.0,Toxicity to various agents,6,16210333
1,22.0,Disease progression,6,16210333
2,22.0,Disease recurrence,6,16210333
3,22.0,Disease progression,6,16210333
4,22.0,Disease progression,6,16210333
5,22.0,Hypersensitivity,6,16210333
6,22.0,Haematotoxicity,6,16210333
7,22.0,Therapy partial responder,6,16210333
8,22.0,Peripheral sensory neuropathy,2,16210333
0,22.0,Abdominal distension,1,16210342
1,22.0,General physical health deterioration,6,16210342
0,22.0,Pneumonitis,6,16210346
1,22.0,Uterine leiomyoma,6,16210346
2,22.0,Lacunar infarction,6,16210346
3,22.0,Leiomyoma,6,16210346
4,22.0,Pericardial effusion,6,16210346
5,22.0,Diarrhoea,6,16210346
6,22.0,Muscular weakness,6,16210346
0,22.0,Pain,6,16210398
1,22.0,Nausea,6,16210398
2,22.0,Arthralgia,6,16210398
3,22.0,Arthritis,6,16210398
4,22.0,Diarrhoea,6,16210398
5,22.0,Poor quality sleep,6,16210398
6,22.0,Sjogren^s syndrome,6,16210398
7,22.0,Viral infection,6,16210398
8,22.0,Asthenia,6,16210398
9,22.0,Fatigue,6,16210398
0,22.0,Nausea,1,16210405
1,22.0,Bronchitis,1,16210405
2,22.0,Rash,6,16210405
3,22.0,Pleural effusion,1,16210405
4,22.0,Pyrexia,1,16210405
0,22.1,Blood alkaline phosphatase abnormal,1,16210414
1,22.1,Fatigue,6,16210414
2,22.1,Aspartate aminotransferase increased,1,16210414
3,22.1,Gamma-glutamyltransferase increased,1,16210414
4,22.1,Alanine aminotransferase increased,1,16210414
5,22.1,Hepatic enzyme increased,2,16210414
0,22.0,Pneumonia aspiration,3,16210477
1,22.0,Abdominal hernia,6,16210477
2,22.0,Haematemesis,3,16210477
0,22.1,Headache,6,16210501
1,22.1,Confusional state,6,16210501
2,22.1,Nervous system disorder,6,16210501
3,22.1,Lymphadenopathy,6,16210501
4,22.1,Hepatic failure,6,16210501
5,22.1,Dysarthria,6,16210501
6,22.1,Ovarian cancer metastatic,6,16210501
7,22.1,Hydrocephalus,6,16210501
0,22.0,Disease progression,6,16210520
1,22.0,Blood creatinine increased,6,16210520
2,22.0,Pancytopenia,6,16210520
3,22.0,Drug ineffective,6,16210520
4,22.0,Pyelonephritis acute,6,16210520
5,22.0,Acute kidney injury,6,16210520
6,22.0,Sepsis,6,16210520
0,22.0,Enterocolitis,1,16210521
0,22.0,Neoplasm recurrence,6,16210591
0,22.0,Road traffic accident,6,16210707
0,22.0,Cholangitis,1,16210721
0,22.1,Sensory loss,6,16210755
1,22.1,General physical health deterioration,5,16210755
2,22.1,Paraesthesia,6,16210755
0,22.0,Death,5,16210761
0,22.0,Schizophrenia,1,16210772
1,22.0,Anaemia,1,16210772
2,22.0,Stomatitis,1,16210772
3,22.0,Suicide attempt,1,16210772
0,22.0,Adverse event,6,16210787
1,22.0,Product use in unapproved indication,6,16210787
0,22.0,Inappropriate schedule of product administration,6,16210803
1,22.0,Neutropenia,1,16210803
0,22.0,Influenza,1,16210827
1,22.0,Interstitial lung disease,2,16210827
2,22.0,Malaise,6,16210827
0,22.0,Disease progression,5,16210847
0,22.0,Fall,5,16210886
0,22.0,Tremor,6,16210894
0,22.0,Gastrointestinal disorder,6,16210914
1,22.0,Chronic hepatitis,6,16210914
2,22.0,Bone marrow failure,6,16210914
3,22.0,Gastrointestinal oedema,6,16210914
0,22.0,Alopecia,3,16210949
0,22.0,Ovarian cancer,5,16210953
1,22.0,Renal disorder,6,16210953
0,22.0,Interstitial lung disease,1,16210981
0,22.0,Terminal state,6,16211025
0,22.0,Haematotoxicity,6,16211047
1,22.0,Erysipelas,6,16211047
0,22.1,Musculoskeletal discomfort,6,16211054
1,22.1,Heart rate irregular,1,16211054
2,22.1,Alopecia,3,16211054
3,22.1,Constipation,6,16211054
4,22.1,Arrhythmia,6,16211054
5,22.1,Emotional disorder,3,16211054
6,22.1,Disease progression,6,16211054
7,22.1,Nasopharyngitis,6,16211054
8,22.1,Urinary tract infection,6,16211054
9,22.1,Lethargy,1,16211054
10,22.1,Carbohydrate antigen 125 increased,6,16211054
11,22.1,Red blood cell count decreased,6,16211054
0,22.0,Hepatic encephalopathy,1,16211090
0,22.0,Death,5,16211101
1,22.0,Intentional product use issue,5,16211101
2,22.0,Off label use,5,16211101
0,22.0,Rib fracture,3,16211110
1,22.0,Muscle rigidity,3,16211110
2,22.0,Gait disturbance,3,16211110
3,22.0,Fall,1,16211110
4,22.0,Device dislocation,1,16211110
5,22.0,Device issue,3,16211110
6,22.0,Scapula fracture,3,16211110
7,22.0,Fall,3,16211110
8,22.0,Loss of personal independence in daily activities,3,16211110
9,22.0,Weight decreased,2,16211110
10,22.0,Fatigue,3,16211110
0,22.0,Photosensitivity reaction,,16211125
1,22.0,Neuropathy peripheral,,16211125
2,22.0,Dyspepsia,,16211125
0,22.0,Terminal state,3,16211173
0,22.0,Diarrhoea,,16211200
1,22.0,Nausea,,16211200
0,22.0,Chills,6,16211215
1,22.0,Fatigue,6,16211215
0,22.0,Photophobia,1,16211256
1,22.0,Retinopathy,1,16211256
0,22.0,Anaemia,2,16211258
1,22.0,Thrombocytopenia,1,16211258
2,22.0,Leukopenia,1,16211258
3,22.0,Off label use,6,16211258
0,22.0,General physical health deterioration,3,16211264
0,22.0,Death,5,16211274
0,22.0,Radiation pneumonitis,5,16211290
1,22.0,Pulmonary embolism,5,16211290
2,22.0,Pneumonia,5,16211290
3,22.0,Toxic epidermal necrolysis,5,16211290
0,22.0,White blood cell count decreased,,16211293
0,22.0,Thrombocytopenia,,16211303
0,22.0,Alveolitis,5,16211325
1,22.0,Hypoxia,5,16211325
2,22.0,Atrial fibrillation,5,16211325
0,22.0,Death,5,16211380
0,22.1,Death,5,16211383
0,22.0,Rectal cancer stage II,5,16211392
1,22.0,Dermatitis,6,16211392
2,22.0,Malignant neoplasm progression,5,16211392
3,22.0,Rectal cancer recurrent,6,16211392
4,22.0,Product use in unapproved indication,6,16211392
0,22.0,Death,,16211395
0,22.0,Thrombocytopenia,1,16211420
0,22.0,Off label use,5,16211429
1,22.0,Intentional product use issue,5,16211429
2,22.0,Death,5,16211429
0,22.0,Pneumonia,1,16211437
0,22.0,Neutropenia,6,16211466
1,22.0,Encephalopathy,6,16211466
0,22.0,Breast cancer metastatic,6,16211474
1,22.0,Malignant neoplasm progression,6,16211474
0,22.0,Hospitalisation,,16211483
0,22.0,Paraesthesia,6,16211550
1,22.0,Diarrhoea,6,16211550
2,22.0,Paraesthesia oral,6,16211550
3,22.0,Blood pressure increased,6,16211550
0,22.0,Blood creatinine increased,1,16211602
1,22.0,Alanine aminotransferase increased,1,16211602
2,22.0,Anaemia,3,16211602
3,22.0,White blood cell count decreased,1,16211602
0,22.0,Anaemia,3,16211619
1,22.0,Intestinal metastasis,6,16211619
0,22.0,Off label use,6,16211624
1,22.0,Drug intolerance,6,16211624
2,22.0,Cellulitis,6,16211624
3,22.0,Fatigue,3,16211624
0,22.0,Toxicity to various agents,3,16211638
1,22.0,Malaise,3,16211638
2,22.0,Myalgia,3,16211638
3,22.0,Fatigue,3,16211638
4,22.0,Nausea,3,16211638
5,22.0,Feeling abnormal,3,16211638
6,22.0,Decreased appetite,3,16211638
0,22.0,Drug resistance,6,16211650
1,22.0,Product quality issue,6,16211650
2,22.0,Mobility decreased,2,16211650
3,22.0,Prostatic specific antigen increased,2,16211650
4,22.0,Underdose,6,16211650
5,22.0,Upper limb fracture,2,16211650
0,22.0,Hypopituitarism,2,16211675
0,22.0,Interstitial lung disease,4,16211699
1,22.0,Pulmonary fibrosis,3,16211699
0,22.0,Tumour haemorrhage,6,16211714
1,22.0,Metastases to lung,6,16211714
2,22.0,Colon cancer,,16211714
0,22.0,Pneumonia,5,16211762
1,22.0,Pulmonary embolism,5,16211762
2,22.0,Toxic epidermal necrolysis,5,16211762
3,22.0,Radiation pneumonitis,5,16211762
0,22.1,Pneumonia,6,16211764
1,22.1,Toxic epidermal necrolysis,6,16211764
2,22.1,Ocular hyperaemia,6,16211764
3,22.1,Somnolence,6,16211764
4,22.1,Arthralgia,6,16211764
5,22.1,Pain in extremity,6,16211764
6,22.1,Pulmonary embolism,6,16211764
7,22.1,Pain of skin,6,16211764
8,22.1,Radiation pneumonitis,6,16211764
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,,16211770
0,22.1,Pneumonia,1,16211814
0,22.0,Acute kidney injury,1,16211878
0,22.0,Disease progression,,16211902
0,22.0,Erythema,1,16211922
1,22.0,Laryngeal oedema,1,16211922
0,22.0,Fatigue,1,16211925
1,22.0,Febrile neutropenia,1,16211925
2,22.0,White blood cell count decreased,6,16211925
3,22.0,Body temperature increased,6,16211925
4,22.0,Neutrophil count decreased,6,16211925
5,22.0,Haemoglobin decreased,6,16211925
0,22.1,Radiation pneumonitis,2,16211927
1,22.1,Malignant neoplasm progression,6,16211927
2,22.1,General physical condition abnormal,2,16211927
3,22.1,Overdose,1,16211927
4,22.1,Appendiceal abscess,2,16211927
5,22.1,Anaemia,2,16211927
6,22.1,Off label use,1,16211927
7,22.1,Diarrhoea,2,16211927
0,22.0,Musculoskeletal stiffness,3,16211942
1,22.0,Fatigue,6,16211942
2,22.0,Electrocardiogram T wave abnormal,1,16211942
3,22.0,Visual impairment,3,16211942
4,22.0,Vertigo,3,16211942
5,22.0,Hot flush,3,16211942
6,22.0,Gastrointestinal disorder,3,16211942
7,22.0,Electrocardiogram repolarisation abnormality,1,16211942
8,22.0,Headache,3,16211942
0,22.0,Cardiac arrest,5,16211963
0,22.0,Pruritus,,16211977
0,22.0,Off label use,6,16211980
1,22.0,Intestinal obstruction,5,16211980
2,22.0,Intestinal ischaemia,5,16211980
0,22.0,Metastasis,3,16211992
1,22.0,Prostate cancer,3,16211992
0,22.0,Sepsis,5,16212078
0,22.0,Haematochezia,1,16212127
1,22.0,Diarrhoea,1,16212127
2,22.0,Abdominal pain,1,16212127
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,2,16212131
1,22.0,Blood bilirubin increased,2,16212131
2,22.0,Metastases to liver,,16212131
3,22.0,Erythema,2,16212131
0,22.0,Stomatitis,6,16212134
1,22.0,Dehydration,6,16212134
2,22.0,Embolism,5,16212134
3,22.0,Shock,5,16212134
0,22.0,Urinary tract infection,6,16212265
1,22.0,Inappropriate schedule of product administration,6,16212265
2,22.0,Groin pain,6,16212265
3,22.0,Urinary retention,6,16212265
0,22.0,Daydreaming,1,16212323
1,22.0,Epistaxis,6,16212323
0,22.0,Eczema,1,16212325
1,22.0,Neoplasm progression,3,16212325
0,22.0,Urinary tract infection,1,16212377
1,22.0,Discoloured vomit,1,16212377
2,22.0,Blood pressure increased,1,16212377
3,22.0,Nausea,1,16212377
4,22.0,Malaise,2,16212377
5,22.0,Hypophagia,1,16212377
0,22.0,Ageusia,1,16212490
1,22.0,Pleural effusion,6,16212490
2,22.0,Neoplasm progression,3,16212490
0,22.0,Hypertension,1,16212496
1,22.0,Proteinuria,1,16212496
0,22.0,Blindness,1,16212521
1,22.0,Retinopathy,1,16212521
0,22.0,Nausea,6,16212538
1,22.0,Feeling abnormal,6,16212538
2,22.0,Headache,6,16212538
0,22.0,Nausea,1,16212550
0,22.0,Therapy cessation,6,16212576
1,22.0,Haemorrhage,6,16212576
0,22.0,Colitis,1,16212586
1,22.0,Pulmonary embolism,6,16212586
2,22.0,Upper gastrointestinal haemorrhage,1,16212586
3,22.0,Atrial fibrillation,6,16212586
0,22.0,Toxicity to various agents,2,16212588
0,22.0,Neutrophil count decreased,1,16212751
0,22.0,Influenza like illness,6,16212873
1,22.0,Neutropenia,1,16212873
0,22.0,Oesophageal stenosis,6,16212894
0,22.1,Alopecia,3,16212905
1,22.1,Hair texture abnormal,3,16212905
2,22.1,Hair colour changes,3,16212905
3,22.1,Hair disorder,3,16212905
0,22.0,Symptom masked,6,16212917
0,22.1,Off label use,6,16212929
1,22.1,Pulmonary embolism,5,16212929
0,22.0,Tinnitus,3,16212941
1,22.0,Tympanic membrane disorder,3,16212941
2,22.0,Deafness,3,16212941
0,22.0,Interstitial lung disease,2,16212954
1,22.0,Dermatitis acneiform,2,16212954
2,22.0,Malignant neoplasm progression,5,16212954
0,22.0,Death,5,16212964
0,22.0,Death,5,16212990
0,22.0,Nail growth abnormal,6,16212993
1,22.0,Madarosis,3,16212993
2,22.0,Hair texture abnormal,6,16212993
3,22.0,Alopecia,6,16212993
0,22.1,Madarosis,3,16212994
1,22.1,Alopecia,3,16212994
2,22.1,Hair texture abnormal,3,16212994
3,22.1,Hair disorder,3,16212994
4,22.1,Hair colour changes,3,16212994
0,22.0,Rash maculo-papular,6,16212999
1,22.0,Breath sounds abnormal,6,16212999
2,22.0,Tachypnoea,6,16212999
3,22.0,Disseminated intravascular coagulation,6,16212999
4,22.0,Bacillus infection,6,16212999
5,22.0,Pyrexia,6,16212999
6,22.0,Loss of consciousness,6,16212999
7,22.0,Multiple organ dysfunction syndrome,6,16212999
8,22.0,General physical condition abnormal,2,16212999
9,22.0,Oedema peripheral,6,16212999
10,22.0,Ocular icterus,6,16212999
11,22.0,Malaise,6,16212999
12,22.0,Respiratory failure,6,16212999
13,22.0,Urine output decreased,6,16212999
14,22.0,Rash generalised,6,16212999
15,22.0,Feeling abnormal,6,16212999
16,22.0,Pulmonary embolism,6,16212999
17,22.0,Oxygen consumption increased,6,16212999
0,22.0,Acute kidney injury,2,16213049
1,22.0,Lactic acidosis,1,16213049
2,22.0,Sinus tachycardia,6,16213049
3,22.0,Diarrhoea,1,16213049
4,22.0,Left ventricular hypertrophy,6,16213049
0,22.0,Pulmonary infarction,1,16213050
1,22.0,Deep vein thrombosis,1,16213050
0,22.0,Neutropenia,1,16213078
1,22.0,Fatigue,1,16213078
2,22.0,Lethargy,6,16213078
3,22.0,Dry mouth,1,16213078
4,22.0,Dry eye,1,16213078
5,22.0,Hypoaesthesia,6,16213078
6,22.0,Leukopenia,3,16213078
7,22.0,Neuropathy peripheral,3,16213078
0,22.0,Myocardial infarction,6,16213102
1,22.0,Cerebrovascular accident,6,16213102
0,22.0,Asthenia,,16213121
1,22.0,Wrong technique in product usage process,,16213121
2,22.0,Thrombosis,,16213121
3,22.0,Nausea,,16213121
4,22.0,Asthenia,,16213121
5,22.0,Headache,3,16213121
6,22.0,Vomiting,3,16213121
7,22.0,Pelvic neoplasm,,16213121
8,22.0,Fatigue,,16213121
9,22.0,Dizziness,3,16213121
10,22.0,Off label use,,16213121
0,22.0,Acute myocardial infarction,1,16213124
0,22.0,Breast cancer recurrent,3,16213148
1,22.0,Asthenia,2,16213148
2,22.0,Influenza like illness,1,16213148
3,22.0,Nausea,6,16213148
4,22.0,Myalgia,2,16213148
5,22.0,Product dose omission,1,16213148
6,22.0,Pain,2,16213148
7,22.0,Chills,2,16213148
8,22.0,Pruritus,6,16213148
9,22.0,Dizziness,1,16213148
10,22.0,Thrombosis,1,16213148
0,22.0,Product dose omission,6,16213256
1,22.0,Lacrimation increased,2,16213256
2,22.0,Seasonal allergy,6,16213256
0,22.0,Alopecia,3,16213257
1,22.0,Hair colour changes,3,16213257
2,22.0,Hair texture abnormal,3,16213257
3,22.0,Hair disorder,3,16213257
0,22.0,Asthenia,1,16213285
1,22.0,Hyponatraemia,3,16213285
2,22.0,Vomiting,1,16213285
0,22.0,Disease progression,6,16213509
1,22.0,Breast cancer recurrent,6,16213509
2,22.0,Metastases to liver,6,16213509
0,22.0,Oedema peripheral,1,16213510
1,22.0,Lichenoid keratosis,1,16213510
0,22.0,Dry skin,3,16213511
1,22.0,Dermatitis acneiform,3,16213511
2,22.0,Aphthous ulcer,3,16213511
3,22.0,Gastrointestinal motility disorder,3,16213511
4,22.0,Asthenia,3,16213511
0,22.0,Dyspnoea,1,16213512
1,22.0,Chest discomfort,1,16213512
2,22.0,Anxiety,1,16213512
3,22.0,Hypersensitivity,1,16213512
0,22.0,Death,5,16213528
1,22.0,Gene mutation identification test positive,6,16213528
0,22.0,Surgery,6,16213547
1,22.0,Constipation,3,16213547
2,22.0,Hypertension,6,16213547
3,22.0,Neutrophil count decreased,1,16213547
4,22.0,Blood count abnormal,1,16213547
5,22.0,Thrombocytopenia,1,16213547
6,22.0,White blood cell count decreased,1,16213547
7,22.0,Inappropriate schedule of product administration,6,16213547
8,22.0,Product dose omission,6,16213547
0,22.0,Acute kidney injury,4,16213593
1,22.0,Anaemia,4,16213593
2,22.0,Leukopenia,6,16213593
0,22.0,Cerebrovascular accident,2,16213608
0,22.0,Major depression,6,16213618
0,22.0,Hypertensive crisis,2,16213619
1,22.0,Drug ineffective,2,16213619
0,22.0,General physical health deterioration,5,16213654
0,22.0,Metastases to bone,6,16213664
1,22.0,Angina pectoris,6,16213664
2,22.0,Multiple organ dysfunction syndrome,5,16213664
0,22.0,Pulmonary oedema,6,16213709
1,22.0,Skin disorder,1,16213709
0,22.0,Vertigo,6,16213719
1,22.0,Dyspnoea,6,16213719
2,22.0,Haemoglobin decreased,6,16213719
3,22.0,Platelet count decreased,6,16213719
0,22.0,Interstitial lung disease,2,16213720
0,22.0,Fatigue,6,16213784
1,22.0,Muscle tightness,6,16213784
2,22.0,Neuropathy peripheral,6,16213784
0,22.0,Haematemesis,5,16213828
1,22.0,Rash,1,16213828
2,22.0,Hypertension,6,16213828
0,22.0,Neoplasm malignant,5,16213836
0,22.1,Venous thrombosis limb,1,16213844
1,22.1,Pulpitis dental,1,16213844
2,22.1,Fatigue,3,16213844
3,22.1,Oedema,3,16213844
4,22.1,Malaise,3,16213844
5,22.1,Mouth ulceration,1,16213844
6,22.1,Neuropathy peripheral,3,16213844
0,22.0,Pleural effusion,6,16213855
1,22.0,Ear pain,6,16213855
2,22.0,Oxygen saturation increased,6,16213855
3,22.0,Loss of consciousness,6,16213855
4,22.0,Ejection fraction decreased,6,16213855
5,22.0,Blood glucose decreased,6,16213855
6,22.0,Dyspnoea,6,16213855
7,22.0,Hypotension,6,16213855
8,22.0,Cardio-respiratory arrest,5,16213855
9,22.0,Neoplasm progression,5,16213855
10,22.0,Cough,6,16213855
11,22.0,Sinus tachycardia,6,16213855
12,22.0,Respiratory failure,6,16213855
13,22.0,Lethargy,6,16213855
14,22.0,Brain natriuretic peptide increased,6,16213855
15,22.0,Pneumonia,6,16213855
16,22.0,Lung disorder,6,16213855
17,22.0,Venous pressure jugular increased,6,16213855
18,22.0,Hypoxia,6,16213855
19,22.0,Fatigue,6,16213855
0,22.0,Death,5,16213858
0,22.0,Hypertension,1,16213969
1,22.0,Dyspnoea,1,16213969
2,22.0,Malaise,1,16213969
3,22.0,Bronchospasm,1,16213969
4,22.0,Tachycardia,1,16213969
5,22.0,Hypersensitivity,1,16213969
6,22.0,Erythema,1,16213969
0,22.0,Type 2 diabetes mellitus,4,16213970
0,22.0,Acute kidney injury,2,16213979
1,22.0,Lactic acidosis,1,16213979
0,22.0,Drug ineffective,6,16214009
1,22.0,Adenocarcinoma,6,16214009
2,22.0,Hepatic cancer recurrent,6,16214009
0,22.0,Tremor,6,16214098
1,22.0,Dizziness,6,16214098
2,22.0,Extra dose administered,6,16214098
3,22.0,Diarrhoea,6,16214098
4,22.0,Abdominal pain upper,6,16214098
5,22.0,Product dose omission,6,16214098
0,22.0,Diarrhoea,3,16214132
1,22.0,Colitis,3,16214132
0,22.0,Hypertension,6,16214139
1,22.0,Diarrhoea,6,16214139
2,22.0,Diabetic metabolic decompensation,6,16214139
0,22.1,Oesophageal perforation,1,16214140
0,22.0,Blister,6,16214168
1,22.0,Hypotension,6,16214168
2,22.0,Weight decreased,6,16214168
3,22.0,Confusional state,6,16214168
4,22.0,Nausea,6,16214168
5,22.0,Vomiting,6,16214168
6,22.0,Blood pressure increased,6,16214168
7,22.0,Somnolence,6,16214168
8,22.0,Fatigue,6,16214168
9,22.0,Decreased appetite,6,16214168
10,22.0,Asthenia,6,16214168
11,22.0,Balance disorder,6,16214168
12,22.0,Diarrhoea,6,16214168
0,22.1,Adrenal insufficiency,3,16214177
1,22.1,Epiglottitis,1,16214177
2,22.1,Drug-induced liver injury,1,16214177
3,22.1,Dyspnoea,1,16214177
0,22.0,Neoplasm progression,3,16214256
0,22.0,Hair disorder,3,16214288
1,22.0,Hair colour changes,3,16214288
2,22.0,Madarosis,3,16214288
3,22.0,Hair texture abnormal,3,16214288
4,22.0,Alopecia,3,16214288
0,22.0,White blood cell count decreased,6,16214289
0,22.0,Dyspnoea,2,16214328
0,22.0,Chronic kidney disease,6,16214338
1,22.0,Renal failure,3,16214338
0,22.0,Cardiac failure,5,16214348
1,22.0,Neoplasm progression,5,16214348
0,22.0,Osteonecrosis of jaw,3,16214350
1,22.0,Dental fistula,3,16214350
2,22.0,Cellulitis,3,16214350
0,22.0,Adrenal insufficiency,1,16214472
0,22.0,Bronchostenosis,1,16214659
1,22.0,Bronchiectasis,6,16214659
2,22.0,Pneumonia,6,16214659
3,22.0,Superior vena cava occlusion,6,16214659
4,22.0,Immune-mediated adverse reaction,6,16214659
5,22.0,Lymphadenopathy,6,16214659
6,22.0,Pulmonary embolism,6,16214659
7,22.0,Nephrolithiasis,6,16214659
8,22.0,Atrial thrombosis,6,16214659
9,22.0,Dysphonia,2,16214659
10,22.0,Tracheomalacia,6,16214659
11,22.0,Malignant neoplasm progression,6,16214659
12,22.0,Cardiac myxoma,6,16214659
13,22.0,Emphysema,6,16214659
0,22.0,Death,5,16214660
0,22.0,Febrile neutropenia,1,16214672
1,22.0,Chest pain,6,16214672
2,22.0,Odynophagia,6,16214672
0,22.0,Death,,16214995
0,22.0,Leukaemic lymphoma,5,16215030
1,22.0,Second primary malignancy,5,16215030
2,22.0,Diffuse large B-cell lymphoma,5,16215030
0,22.0,Pancreatitis,,16215039
1,22.0,Therapy cessation,,16215039
0,22.0,Immune-mediated hepatitis,1,16215045
1,22.0,Respiratory failure,1,16215045
2,22.0,Hepatic enzyme increased,1,16215045
3,22.0,Renal failure,6,16215045
4,22.0,Death,5,16215045
5,22.0,Cholecystitis acute,1,16215045
6,22.0,Hyperkalaemia,6,16215045
7,22.0,Adverse event,6,16215045
0,22.0,Groin pain,6,16215057
1,22.0,Back pain,6,16215057
0,22.0,Malaise,,16215113
1,22.0,Adverse drug reaction,,16215113
0,22.0,Herpes zoster,1,16215127
1,22.0,Malignant neoplasm progression,5,16215127
2,22.0,Rash,1,16215127
3,22.0,Skin ulcer,1,16215127
0,22.0,Vomiting,,16215135
1,22.0,Constipation,,16215135
0,22.0,Seizure,6,16215182
1,22.0,Chills,6,16215182
2,22.0,Discomfort,6,16215182
3,22.0,Hyperhidrosis,6,16215182
4,22.0,Suspected product quality issue,6,16215182
5,22.0,Pyrexia,6,16215182
0,22.0,Anal abscess,4,16215188
0,22.0,Hypoxia,,16215250
1,22.0,Pneumonitis,,16215250
0,22.0,Hepatic function abnormal,2,16215265
1,22.0,Gamma-glutamyltransferase increased,2,16215265
2,22.0,Aspartate aminotransferase increased,2,16215265
3,22.0,Alanine aminotransferase increased,2,16215265
4,22.0,Blood alkaline phosphatase increased,2,16215265
0,22.0,Thrombocytopenia,1,16215306
1,22.0,Acute kidney injury,1,16215306
2,22.0,Neutropenia,1,16215306
3,22.0,Leukopenia,1,16215306
4,22.0,Pancytopenia,1,16215306
0,22.0,Neurotoxicity,6,16215318
1,22.0,Off label use,3,16215318
2,22.0,Therapy naive,3,16215318
0,22.0,Lactic acidosis,1,16215325
1,22.0,Coma,1,16215325
2,22.0,Acute kidney injury,2,16215325
3,22.0,Hyperkalaemia,1,16215325
4,22.0,Shock,1,16215325
5,22.0,Dehydration,1,16215325
6,22.0,Vomiting,1,16215325
7,22.0,Diarrhoea,1,16215325
0,22.0,Left ventricular failure,,16215372
0,22.0,Hepatic function abnormal,1,16215404
1,22.0,Dermatitis acneiform,6,16215404
2,22.0,Autoimmune haemolytic anaemia,3,16215404
3,22.0,Lung disorder,1,16215404
0,22.0,Disease progression,,16215425
0,22.0,Disease progression,,16215443
0,22.0,Colitis,,16215449
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,,16215454
1,22.0,Paraesthesia,,16215454
2,22.0,Erythema,,16215454
0,22.0,Rash,,16215465
0,22.0,Death,,16215500
0,22.0,Pain,6,16215622
1,22.0,Cardiovascular insufficiency,6,16215622
2,22.0,Toxic epidermal necrolysis,5,16215622
0,22.0,Death,,16215625
0,22.0,Fatigue,1,16215658
1,22.0,Nausea,6,16215658
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16215658
0,22.0,Chills,6,16215678
1,22.0,Hypotension,6,16215678
2,22.0,Pyrexia,6,16215678
0,22.0,Neutropenia,6,16215704
1,22.0,Large intestine perforation,1,16215704
2,22.0,Pneumoperitoneum,1,16215704
3,22.0,Stomal hernia,1,16215704
0,22.0,Respiratory failure,5,16215920
0,22.0,Type V hyperlipidaemia,6,16215926
1,22.0,Pleural effusion,6,16215926
2,22.0,Decreased appetite,6,16215926
3,22.0,Systemic inflammatory response syndrome,6,16215926
4,22.0,Leukopenia,6,16215926
5,22.0,Metastases to peritoneum,6,16215926
6,22.0,Ovarian cancer stage III,6,16215926
7,22.0,Deep vein thrombosis,6,16215926
8,22.0,Essential hypertension,6,16215926
9,22.0,Hypokalaemia,6,16215926
10,22.0,Fallopian tube cancer,6,16215926
11,22.0,Malignant ascites,6,16215926
12,22.0,Hyponatraemia,6,16215926
13,22.0,Atelectasis,6,16215926
14,22.0,Acute kidney injury,6,16215926
15,22.0,Febrile neutropenia,1,16215926
16,22.0,Metastatic neoplasm,6,16215926
0,22.0,No adverse event,6,16215929
0,22.0,Pulmonary sarcoidosis,2,16215942
1,22.0,Eosinophilia,2,16215942
0,22.0,Death,5,16216045
0,22.0,Deep vein thrombosis,1,16216165
0,22.0,Parotitis,2,16216263
1,22.0,Anaphylactic reaction,2,16216263
2,22.0,Generalised erythema,2,16216263
0,22.0,Anaphylactic reaction,2,16216265
1,22.0,Generalised erythema,2,16216265
0,22.0,Anaphylactic reaction,2,16216266
1,22.0,Generalised erythema,2,16216266
0,22.0,Hypoxia,2,16216267
1,22.0,Anaphylactic reaction,2,16216267
0,22.0,Oxygen saturation decreased,6,16216289
1,22.0,Stridor,6,16216289
2,22.0,Cyanosis,6,16216289
3,22.0,Cholangiocarcinoma,5,16216289
4,22.0,Acute respiratory failure,5,16216289
0,22.0,Cardiac failure congestive,2,16216347
1,22.0,Troponin I increased,2,16216347
2,22.0,Drug intolerance,2,16216347
3,22.0,Ejection fraction decreased,2,16216347
0,22.0,Cardiac failure congestive,2,16216363
1,22.0,Ejection fraction decreased,2,16216363
2,22.0,Drug intolerance,2,16216363
3,22.0,Troponin I increased,2,16216363
0,22.0,Product use in unapproved indication,6,16216381
1,22.0,White blood cell count decreased,6,16216381
0,22.0,Abdominal distension,3,16216427
1,22.0,Diarrhoea,1,16216427
2,22.0,Oesophageal pain,3,16216427
3,22.0,Nausea,3,16216427
4,22.0,Fatigue,3,16216427
5,22.0,Gingival bleeding,1,16216427
6,22.0,Vomiting,3,16216427
7,22.0,Oesophageal varices haemorrhage,1,16216427
0,22.0,Bone pain,3,16216466
1,22.0,Hypertensive urgency,3,16216466
2,22.0,Polyneuropathy,3,16216466
3,22.0,Somnolence,3,16216466
4,22.0,Dyspnoea,3,16216466
5,22.0,Cough,3,16216466
6,22.0,Heart rate irregular,3,16216466
7,22.0,Hypotension,3,16216466
8,22.0,Nausea,3,16216466
9,22.0,Breast pain,3,16216466
10,22.0,Headache,3,16216466
11,22.0,Dizziness,3,16216466
12,22.0,Visual impairment,3,16216466
13,22.0,Bowel movement irregularity,3,16216466
14,22.0,Onychoclasis,3,16216466
15,22.0,Myalgia,3,16216466
16,22.0,Tremor,3,16216466
17,22.0,Drug intolerance,6,16216466
18,22.0,Abdominal discomfort,3,16216466
0,22.0,Viral infection,2,16216467
1,22.0,Localised infection,6,16216467
2,22.0,Hypoaesthesia,2,16216467
3,22.0,Leukopenia,2,16216467
4,22.0,Abdominal pain,2,16216467
5,22.0,Fatigue,2,16216467
6,22.0,Anaemia,1,16216467
7,22.0,Cough,2,16216467
8,22.0,Constipation,2,16216467
9,22.0,Pruritus,6,16216467
0,22.0,Decreased immune responsiveness,6,16216474
1,22.0,Neoplasm progression,3,16216474
2,22.0,Anaemia,3,16216474
0,22.0,Pulmonary arterial hypertension,3,16216496
0,22.0,Urticaria,3,16216545
1,22.0,Neoplasm,6,16216545
2,22.0,Hypersensitivity,3,16216545
3,22.0,Skin reaction,1,16216545
0,22.0,Platelet count decreased,1,16216626
1,22.0,Neuropathy peripheral,6,16216626
2,22.0,White blood cell count decreased,1,16216626
3,22.0,Neutrophil count decreased,1,16216626
0,22.0,Haemorrhage,6,16216650
0,22.1,Pneumonia influenzal,1,16216681
1,22.1,Type 2 diabetes mellitus,1,16216681
2,22.1,Breast cancer metastatic,5,16216681
3,22.1,Hyperglycaemia,1,16216681
4,22.1,Syncope,1,16216681
5,22.1,Myopathy,1,16216681
6,22.1,Malignant neoplasm progression,5,16216681
7,22.1,Abdominal distension,5,16216681
8,22.1,Renal pain,5,16216681
9,22.1,Ascites,5,16216681
0,22.0,Leukopenia,3,16216722
1,22.0,Neutropenia,1,16216722
2,22.0,Leukopenia,1,16216722
3,22.0,Neutropenia,1,16216722
0,22.0,Unintentional medical device removal,6,16216737
1,22.0,Accidental exposure to product,6,16216737
0,22.0,Ventricular fibrillation,2,16216746
1,22.0,Cardiac failure congestive,2,16216746
2,22.0,Long QT syndrome,2,16216746
3,22.0,Inappropriate schedule of product administration,6,16216746
4,22.0,Torsade de pointes,2,16216746
0,22.0,Pancreatitis,6,16216757
0,22.0,Neuropathy peripheral,3,16216806
0,22.0,Product use in unapproved indication,6,16216836
1,22.0,Death,5,16216836
0,22.0,Death,5,16216856
0,22.1,Pyrexia,1,16216858
1,22.1,Gastrointestinal perforation,1,16216858
2,22.1,Neuropathy peripheral,6,16216858
0,22.0,Dry skin,3,16216903
1,22.0,Neutrophil count decreased,6,16216903
2,22.0,Skin disorder,1,16216903
3,22.0,White blood cell count decreased,1,16216903
4,22.0,Injection site swelling,1,16216903
5,22.0,Incorrect route of product administration,6,16216903
6,22.0,Injection site erythema,1,16216903
7,22.0,Injection site pain,1,16216903
0,22.0,Pyrexia,1,16216914
1,22.0,Cough,2,16216914
2,22.0,Hypoxia,1,16216914
3,22.0,Red blood cell count decreased,2,16216914
4,22.0,Hypotension,2,16216914
5,22.0,Lymphocyte count decreased,2,16216914
0,22.0,Osteonecrosis of jaw,,16217009
1,22.0,Pain in jaw,,16217009
2,22.0,Prostate cancer,,16217009
0,22.0,Septic shock,5,16217029
1,22.0,Colitis,5,16217029
0,22.0,Pulmonary embolism,2,16217052
1,22.0,Cor pulmonale acute,2,16217052
2,22.0,Cardiorenal syndrome,2,16217052
0,22.0,Intestinal operation,1,16217055
0,22.0,Subdural haematoma,5,16217094
1,22.0,Atelectasis,3,16217094
2,22.0,Fall,1,16217094
3,22.0,Head injury,1,16217094
4,22.0,Cerebral haemorrhage,3,16217094
5,22.0,Brain herniation,5,16217094
0,22.0,Asphyxia,1,16217096
1,22.0,Treatment noncompliance,6,16217096
2,22.0,Respiratory tract inflammation,1,16217096
3,22.0,Hypersensitivity,1,16217096
4,22.0,Angioedema,6,16217096
0,22.0,Leiomyoma,1,16217131
0,22.0,Anaemia,6,16217160
1,22.0,Malignant neoplasm progression,6,16217160
0,22.0,Anaphylactic shock,1,16217173
0,22.0,Oxygen saturation decreased,1,16217175
1,22.0,Dyspnoea,1,16217175
2,22.0,Feeling hot,1,16217175
0,22.0,Systemic inflammatory response syndrome,1,16217213
1,22.0,Hypotension,1,16217213
0,22.1,Nausea,1,16217217
0,22.0,Nausea,3,16217232
1,22.0,Nasopharyngitis,3,16217232
2,22.0,Weight increased,3,16217232
3,22.0,Infusion related reaction,3,16217232
4,22.0,Lymphoedema,3,16217232
5,22.0,Blood pressure decreased,3,16217232
6,22.0,Brain neoplasm,3,16217232
7,22.0,Incorrect dose administered,3,16217232
8,22.0,Pyrexia,3,16217232
9,22.0,Haemorrhoids,3,16217232
10,22.0,Tooth disorder,3,16217232
11,22.0,Constipation,3,16217232
12,22.0,Fatigue,3,16217232
13,22.0,Seizure,3,16217232
14,22.0,Urinary tract disorder,3,16217232
15,22.0,Pain,3,16217232
16,22.0,Paranasal sinus discomfort,3,16217232
17,22.0,Weight decreased,3,16217232
0,22.0,Malaise,6,16217336
1,22.0,Fatigue,3,16217336
2,22.0,Aphthous ulcer,1,16217336
3,22.0,White blood cell count decreased,1,16217336
4,22.0,Pain,6,16217336
5,22.0,Rash,1,16217336
0,22.0,Intestinal obstruction,5,16217346
1,22.0,Renal cyst infection,5,16217346
2,22.0,Febrile neutropenia,1,16217346
3,22.0,Septic shock,5,16217346
0,22.0,Feeding disorder,1,16217431
1,22.0,Fatigue,3,16217431
0,22.0,Anaphylactic shock,1,16217520
0,22.0,Product dose omission,6,16217539
1,22.0,Psoriasis,6,16217539
2,22.0,Nausea,6,16217539
3,22.0,Rash,6,16217539
0,22.0,Neoplasm progression,6,16217569
0,22.1,Interstitial lung disease,5,16217656
1,22.1,Deep vein thrombosis,1,16217656
2,22.1,Pulmonary embolism,6,16217656
3,22.1,Device related infection,6,16217656
4,22.1,C-reactive protein increased,6,16217656
5,22.1,Palpitations,6,16217656
6,22.1,Rash,6,16217656
0,22.0,Disseminated intravascular coagulation,1,16217796
1,22.0,Drug hypersensitivity,6,16217796
2,22.0,Acute promyelocytic leukaemia,1,16217796
0,22.0,Death,5,16217878
1,22.0,Bone marrow failure,6,16217878
0,22.0,Intestinal obstruction,3,16217887
1,22.0,Small intestinal obstruction,1,16217887
2,22.0,Intestinal obstruction,1,16217887
3,22.0,Small intestinal obstruction,3,16217887
0,22.0,Dementia,6,16217931
0,22.0,Death,5,16217945
0,22.0,Pleural effusion,3,16218011
0,22.0,Pancytopenia,3,16218024
0,22.0,Dehydration,6,16218029
1,22.0,Fatigue,3,16218029
2,22.0,Ammonia increased,6,16218029
3,22.0,Balance disorder,3,16218029
4,22.0,Diarrhoea,1,16218029
5,22.0,Nausea,3,16218029
6,22.0,Blood pressure increased,3,16218029
7,22.0,Confusional state,3,16218029
0,22.0,Colitis,1,16218033
0,22.1,Oral candidiasis,1,16218083
1,22.1,Dyspnoea,2,16218083
2,22.1,Pneumonia,4,16218083
3,22.1,Peripheral swelling,2,16218083
4,22.1,Cellulitis,2,16218083
5,22.1,Acute kidney injury,2,16218083
0,22.0,Pneumonia,1,16218171
1,22.0,Diarrhoea,1,16218171
2,22.0,Pulmonary embolism,1,16218171
0,22.0,Nausea,6,16218175
1,22.0,Decreased appetite,6,16218175
2,22.0,Vomiting,6,16218175
3,22.0,Hepatotoxicity,6,16218175
0,22.0,Gastrointestinal toxicity,6,16218176
1,22.0,Diabetes mellitus,6,16218176
2,22.0,Urinary tract infection,6,16218176
3,22.0,Haematotoxicity,6,16218176
4,22.0,Cardiotoxicity,6,16218176
0,22.0,Malignant neoplasm progression,6,16218200
1,22.0,Malaise,1,16218200
2,22.0,Nausea,1,16218200
3,22.0,Anaemia,1,16218200
4,22.0,Neutrophil count decreased,1,16218200
0,22.0,Pulmonary embolism,1,16218202
0,22.0,Anxiety,1,16218222
1,22.0,Fatigue,1,16218222
2,22.0,Diarrhoea,1,16218222
3,22.0,Loss of consciousness,1,16218222
4,22.0,Diarrhoea,1,16218222
5,22.0,Constipation,1,16218222
6,22.0,Erythema,1,16218222
0,22.0,Embolism,6,16218225
1,22.0,Metastases to central nervous system,6,16218225
2,22.0,Radiation necrosis,6,16218225
3,22.0,Rash,6,16218225
0,22.0,Off label use,6,16218253
1,22.0,Febrile neutropenia,6,16218253
2,22.0,Influenza like illness,6,16218253
0,22.0,Pulmonary oedema,6,16218271
1,22.0,Metastases to liver,6,16218271
2,22.0,Spinal fracture,6,16218271
3,22.0,Metastases to spine,6,16218271
4,22.0,Decreased appetite,6,16218271
5,22.0,Fatigue,6,16218271
6,22.0,Uterine polyp,6,16218271
7,22.0,Endometrial thickening,6,16218271
8,22.0,Malaise,6,16218271
9,22.0,Cough,6,16218271
10,22.0,Metastases to lung,6,16218271
11,22.0,Breast cancer,6,16218271
12,22.0,Metastases to bone,6,16218271
13,22.0,Oropharyngeal pain,6,16218271
14,22.0,Pyrexia,6,16218271
15,22.0,Vomiting,6,16218271
16,22.0,Malignant neoplasm progression,6,16218271
17,22.0,Dyspnoea,6,16218271
18,22.0,Blood test abnormal,6,16218271
19,22.0,Mucosal inflammation,6,16218271
0,22.0,Hypertension,1,16218293
0,22.0,Neuropathy peripheral,6,16218305
1,22.0,Gingival disorder,6,16218305
2,22.0,Stomatitis,6,16218305
3,22.0,Tinnitus,6,16218305
4,22.0,Unevaluable event,6,16218305
0,22.0,Red blood cell count decreased,6,16218398
1,22.0,Fatigue,6,16218398
2,22.0,Constipation,6,16218398
3,22.0,Back pain,6,16218398
0,22.0,Epistaxis,6,16218403
0,22.0,Pain,3,16218464
1,22.0,Neuropathy peripheral,3,16218464
2,22.0,Burning sensation,3,16218464
3,22.0,Tendonitis,3,16218464
4,22.0,Fatigue,6,16218464
5,22.0,Gait inability,6,16218464
0,22.0,Malignant neoplasm progression,5,16218471
0,22.0,Off label use,6,16218472
1,22.0,Wrong technique in product usage process,6,16218472
2,22.0,Liver disorder,6,16218472
0,22.0,Neutropenia,1,16218501
1,22.0,Thrombocytopenia,1,16218501
2,22.0,Pleural thickening,6,16218501
3,22.0,Leukopenia,1,16218501
0,22.0,Oral herpes,1,16218502
1,22.0,Thrombosis,1,16218502
2,22.0,Glossodynia,1,16218502
3,22.0,Erythema,1,16218502
4,22.0,Fatigue,1,16218502
5,22.0,Intervertebral disc protrusion,1,16218502
6,22.0,Lymphoedema,3,16218502
7,22.0,Pain in extremity,1,16218502
8,22.0,Stomatitis,1,16218502
0,22.1,Breast cancer recurrent,6,16218504
1,22.1,Metastases to spine,3,16218504
2,22.1,Breast swelling,6,16218504
3,22.1,Feeding disorder,6,16218504
4,22.1,Malaise,6,16218504
5,22.1,Swelling face,3,16218504
6,22.1,Diarrhoea,6,16218504
7,22.1,Decreased immune responsiveness,2,16218504
8,22.1,Insomnia,1,16218504
9,22.1,Influenza,2,16218504
10,22.1,Peripheral swelling,3,16218504
11,22.1,Decreased appetite,6,16218504
12,22.1,Abdominal pain upper,6,16218504
13,22.1,Interstitial lung disease,6,16218504
14,22.1,Fatigue,3,16218504
15,22.1,Limb injury,6,16218504
16,22.1,Pain in extremity,3,16218504
17,22.1,Tooth loss,3,16218504
18,22.1,Feeling abnormal,6,16218504
19,22.1,Pleural effusion,6,16218504
20,22.1,Dyspnoea,6,16218504
21,22.1,Skin fissures,2,16218504
22,22.1,Toxicity to various agents,6,16218504
23,22.1,Speech disorder,6,16218504
24,22.1,Inappropriate schedule of product administration,6,16218504
25,22.1,Vomiting,6,16218504
26,22.1,Nausea,6,16218504
27,22.1,Erythema,6,16218504
28,22.1,Dysphagia,6,16218504
29,22.1,Food aversion,6,16218504
30,22.1,Tremor,6,16218504
31,22.1,Mouth injury,6,16218504
32,22.1,Skin discolouration,6,16218504
33,22.1,Pneumonitis,6,16218504
34,22.1,General physical health deterioration,3,16218504
35,22.1,Stress,6,16218504
36,22.1,Injection site pain,3,16218504
37,22.1,Injection site mass,3,16218504
38,22.1,Metastases to pleura,6,16218504
39,22.1,Weight decreased,6,16218504
0,22.0,Bone marrow failure,6,16218546
0,22.0,Nausea,6,16218599
0,22.0,Stomatitis,1,16218617
1,22.0,Stevens-Johnson syndrome,1,16218617
0,22.0,Malignant neoplasm progression,6,16218620
0,22.0,Tongue disorder,6,16218641
1,22.0,Glossitis,6,16218641
2,22.0,Swollen tongue,6,16218641
3,22.0,Accidental overdose,6,16218641
4,22.0,Glossodynia,6,16218641
5,22.0,Intentional product misuse,6,16218641
6,22.0,Fatigue,6,16218641
0,22.0,Neutrophil count decreased,3,16218652
1,22.0,Tooth disorder,6,16218652
2,22.0,Bone disorder,6,16218652
3,22.0,Pleural effusion,6,16218652
4,22.0,White blood cell count decreased,3,16218652
5,22.0,Memory impairment,3,16218652
6,22.0,Body height decreased,6,16218652
0,22.0,Full blood count abnormal,3,16218838
1,22.0,Death,5,16218838
2,22.0,Nausea,3,16218838
3,22.0,Fatigue,3,16218838
0,22.0,Therapeutic product ineffective,,16218853
1,22.0,Diarrhoea,3,16218853
2,22.0,Stoma site irritation,1,16218853
3,22.0,Nausea,1,16218853
4,22.0,Diarrhoea,1,16218853
5,22.0,Fatigue,1,16218853
0,22.0,Stevens-Johnson syndrome,2,16218864
0,22.0,Hypoxia,6,16218872
1,22.0,Death,5,16218872
2,22.0,Concomitant disease progression,6,16218872
3,22.0,Pleural effusion,6,16218872
4,22.0,Dyspnoea,6,16218872
5,22.0,Osteoporosis,6,16218872
6,22.0,Cardiac hypertrophy,6,16218872
7,22.0,Lung disorder,6,16218872
0,22.0,Fatigue,3,16218896
1,22.0,Anaemia,1,16218896
2,22.0,Diarrhoea,1,16218896
3,22.0,Nausea,3,16218896
4,22.0,Burkitt^s lymphoma,3,16218896
0,22.0,Febrile neutropenia,1,16218910
1,22.0,Pneumonia,1,16218910
0,22.0,Jaundice,6,16218914
1,22.0,Alanine aminotransferase increased,1,16218914
2,22.0,Colitis,1,16218914
3,22.0,Stomatitis,1,16218914
4,22.0,Drug-induced liver injury,1,16218914
5,22.0,Transaminases increased,6,16218914
6,22.0,Fatigue,1,16218914
7,22.0,Nausea,6,16218914
8,22.0,Chromaturia,6,16218914
9,22.0,Gamma-glutamyltransferase increased,1,16218914
10,22.0,Diarrhoea,1,16218914
11,22.0,Aspartate aminotransferase increased,1,16218914
0,22.0,Depression,2,16218940
1,22.0,Decreased appetite,2,16218940
2,22.0,Constipation,6,16218940
3,22.0,Somnolence,6,16218940
4,22.0,Cognitive disorder,6,16218940
5,22.0,Insomnia,6,16218940
6,22.0,Fatigue,6,16218940
7,22.0,Sleep apnoea syndrome,6,16218940
8,22.0,Dysphagia,6,16218940
9,22.0,Anxiety,6,16218940
10,22.0,Vomiting,6,16218940
11,22.0,Urinary retention,6,16218940
12,22.0,Dyspnoea,6,16218940
13,22.0,Delirium,6,16218940
14,22.0,Pulmonary embolism,6,16218940
15,22.0,Adverse event,6,16218940
0,22.0,Malaise,3,16218943
0,22.0,Chills,6,16218950
0,22.0,Myocardial infarction,5,16218960
1,22.0,White blood cell count decreased,3,16218960
0,22.0,Neutrophil count decreased,1,16218964
0,22.0,Colitis,6,16218981
1,22.0,Diarrhoea,6,16218981
0,22.0,Cholestasis,1,16218982
1,22.0,Influenza like illness,1,16218982
2,22.0,Hepatitis,1,16218982
0,22.0,Blood immunoglobulin G increased,6,16219000
1,22.0,Neutropenia,6,16219000
0,22.0,Arthritis,1,16219007
0,22.0,Frequent bowel movements,6,16219011
1,22.0,Pulmonary embolism,6,16219011
0,22.0,Gastrointestinal haemorrhage,1,16219017
1,22.0,Gastric ulcer,1,16219017
0,22.0,Malignant neoplasm progression,6,16219042
1,22.0,Metastases to bone,6,16219042
2,22.0,Breast cancer stage IV,6,16219042
0,22.0,Thrombocytopenia,2,16219043
0,22.0,Memory impairment,6,16219054
1,22.0,Asthenia,1,16219054
2,22.0,Constipation,1,16219054
3,22.0,Hair colour changes,1,16219054
4,22.0,Pharyngitis,1,16219054
5,22.0,Decreased appetite,1,16219054
6,22.0,Haemoptysis,1,16219054
7,22.0,Headache,1,16219054
8,22.0,Epistaxis,1,16219054
0,22.0,Neutropenia,3,16219057
0,22.1,Colitis,1,16219062
1,22.1,Acute kidney injury,1,16219062
0,22.0,Anaphylactic shock,6,16219085
1,22.0,Rash,6,16219085
0,22.0,Electrocardiogram QT prolonged,6,16219104
1,22.0,Electrocardiogram repolarisation abnormality,6,16219104
0,22.1,Nephropathy,3,16219143
1,22.1,Renal injury,6,16219143
2,22.1,Renal failure,6,16219143
3,22.1,Rebound acid hypersecretion,6,16219143
4,22.1,Chronic kidney disease,6,16219143
0,22.0,Pneumonitis,2,16219195
0,22.1,Vaginal haemorrhage,1,16219213
1,22.1,Weight decreased,3,16219213
2,22.1,Leukopenia,1,16219213
3,22.1,Neutropenia,3,16219213
0,22.0,Hypersensitivity vasculitis,6,16219228
1,22.0,Henoch-Schonlein purpura,1,16219228
2,22.0,Acute kidney injury,2,16219228
3,22.0,Proteinuria,3,16219228
4,22.0,Dermatitis acneiform,1,16219228
0,22.0,Nausea,6,16219239
0,22.0,Breast cancer recurrent,6,16219247
1,22.0,Metastases to bone,6,16219247
2,22.0,Musculoskeletal chest pain,6,16219247
3,22.0,Bone pain,6,16219247
0,22.0,Dyspnoea,6,16219258
1,22.0,Asthenia,6,16219258
2,22.0,Altered state of consciousness,6,16219258
3,22.0,Pulse absent,6,16219258
0,22.0,Epistaxis,6,16219267
1,22.0,Hepatotoxicity,6,16219267
2,22.0,Alopecia,6,16219267
3,22.0,Peripheral sensory neuropathy,6,16219267
4,22.0,Stomatitis,6,16219267
5,22.0,Nausea,6,16219267
6,22.0,Arthralgia,6,16219267
7,22.0,Body temperature increased,6,16219267
8,22.0,Headache,6,16219267
0,22.1,Pneumonia,6,16219281
1,22.1,Chest discomfort,6,16219281
2,22.1,Immunodeficiency,6,16219281
3,22.1,Ejection fraction decreased,6,16219281
4,22.1,Asthenia,6,16219281
5,22.1,Pericardial effusion,6,16219281
6,22.1,Cardiac failure,6,16219281
7,22.1,Respiratory failure,6,16219281
8,22.1,Pulmonary oedema,6,16219281
9,22.1,Cough,6,16219281
10,22.1,Pleural effusion,6,16219281
11,22.1,Eczema,6,16219281
12,22.1,Leukopenia,6,16219281
13,22.1,Fatigue,6,16219281
14,22.1,Invasive ductal breast carcinoma,3,16219281
15,22.1,Haematoma,6,16219281
16,22.1,Pulmonary embolism,6,16219281
17,22.1,Blood pressure increased,6,16219281
18,22.1,Dyspnoea,6,16219281
19,22.1,Drug intolerance,6,16219281
20,22.1,Acute myocardial infarction,6,16219281
21,22.1,Polyneuropathy,6,16219281
22,22.1,Carotid arteriosclerosis,6,16219281
23,22.1,Hypotension,6,16219281
24,22.1,Hepatic steatosis,6,16219281
0,22.0,Oxygen saturation decreased,1,16219292
1,22.0,Feeling hot,1,16219292
2,22.0,Dyspnoea,1,16219292
0,22.0,Decreased appetite,2,16219411
1,22.0,Renal impairment,2,16219411
2,22.0,Anaemia,6,16219411
0,22.0,Colon cancer recurrent,2,16219413
1,22.0,Disease progression,2,16219413
0,22.0,Endometrial cancer,1,16219422
0,22.0,Off label use,6,16219525
1,22.0,Hypersensitivity,6,16219525
0,22.1,Oedema peripheral,6,16219527
1,22.1,Liver function test increased,3,16219527
2,22.1,Abdominal pain,6,16219527
3,22.1,Mobility decreased,6,16219527
4,22.1,Fatigue,6,16219527
5,22.1,Spinal pain,2,16219527
6,22.1,Nausea,6,16219527
7,22.1,Pain,1,16219527
0,22.0,Breast cancer,6,16219637
1,22.0,Malignant neoplasm progression,6,16219637
0,22.0,Cognitive disorder,6,16219656
1,22.0,Pulmonary embolism,6,16219656
2,22.0,Depression,2,16219656
3,22.0,Vomiting,6,16219656
4,22.0,Anxiety,6,16219656
5,22.0,Fatigue,6,16219656
6,22.0,Dyspnoea,6,16219656
7,22.0,Urinary retention,6,16219656
8,22.0,Somnolence,6,16219656
9,22.0,Delirium,6,16219656
10,22.0,Decreased appetite,2,16219656
11,22.0,Adverse event,6,16219656
12,22.0,Sleep apnoea syndrome,6,16219656
13,22.0,Insomnia,6,16219656
14,22.0,Dysphagia,6,16219656
15,22.0,Constipation,6,16219656
0,22.0,Epididymitis,2,16219664
0,22.0,Metastases to liver,6,16219693
0,22.0,Gastric perforation,1,16219729
0,22.0,Diarrhoea,6,16219746
1,22.0,Neuropathy peripheral,2,16219746
2,22.0,Fatigue,6,16219746
3,22.0,Decreased appetite,6,16219746
4,22.0,Oesophageal spasm,6,16219746
0,22.0,Diarrhoea,2,16219789
1,22.0,Oedema peripheral,6,16219789
2,22.0,Asthenia,6,16219789
3,22.0,Lymphadenopathy,6,16219789
4,22.0,Infective exacerbation of chronic obstructive airways disease,6,16219789
5,22.0,Pruritus generalised,1,16219789
0,22.0,Type 2 diabetes mellitus,4,16219808
0,22.1,Cyanosis,5,16219835
1,22.1,Pulmonary embolism,5,16219835
2,22.1,Somnolence,5,16219835
3,22.1,Confusional state,5,16219835
4,22.1,Swelling,5,16219835
5,22.1,Venous thrombosis,5,16219835
6,22.1,Peripheral swelling,5,16219835
7,22.1,Cardiac arrest,5,16219835
8,22.1,Oedema peripheral,5,16219835
9,22.1,Nausea,1,16219835
10,22.1,Dyspnoea,5,16219835
11,22.1,Drug interaction,5,16219835
12,22.1,Cardio-respiratory arrest,5,16219835
13,22.1,Haemoptysis,5,16219835
14,22.1,Chest pain,5,16219835
15,22.1,Cough,5,16219835
16,22.1,Insomnia,2,16219835
0,22.0,Paraesthesia,2,16219851
1,22.0,Skin toxicity,2,16219851
0,22.0,Haematotoxicity,6,16219864
1,22.0,Toxicity to various agents,6,16219864
0,22.0,Hyporeflexia,3,16219873
1,22.0,Muscle contractions involuntary,3,16219873
2,22.0,Paraesthesia,3,16219873
3,22.0,Asthenia,3,16219873
4,22.0,Dermatitis acneiform,3,16219873
0,22.1,Syncope,2,16219892
1,22.1,Weight decreased,6,16219892
2,22.1,Lacrimation increased,3,16219892
3,22.1,Abdominal pain lower,2,16219892
4,22.1,Circulatory collapse,1,16219892
5,22.1,Constipation,2,16219892
0,22.0,Gene mutation,2,16219895
1,22.0,Cerebellar syndrome,2,16219895
0,22.0,Off label use,6,16219915
1,22.0,Pulmonary mass,6,16219915
0,22.0,Throat irritation,3,16219994
1,22.0,Rhinorrhoea,3,16219994
2,22.0,Cough,3,16219994
3,22.0,Off label use,6,16219994
4,22.0,Product use in unapproved indication,6,16219994
5,22.0,Nasopharyngitis,3,16219994
0,22.1,Interstitial lung disease,5,16220055
0,22.0,Renal impairment,2,16220060
1,22.0,Erythema,1,16220060
0,22.0,Surgery,6,16220064
1,22.0,Product availability issue,6,16220064
2,22.0,Product dose omission,6,16220064
0,22.0,Product dose omission,6,16220073
1,22.0,No adverse event,6,16220073
2,22.0,Product availability issue,6,16220073
0,22.0,Product availability issue,6,16220075
1,22.0,Product dose omission,6,16220075
2,22.0,No adverse event,6,16220075
0,22.0,General physical health deterioration,1,16220197
1,22.0,Confusional state,1,16220197
2,22.0,Colitis,1,16220197
3,22.0,Polyneuropathy,1,16220197
4,22.0,Off label use,1,16220197
5,22.0,Toxicity to various agents,6,16220197
6,22.0,Fatigue,1,16220197
7,22.0,Malignant neoplasm progression,6,16220197
8,22.0,Diarrhoea,1,16220197
9,22.0,Pain,1,16220197
0,22.0,Nephritis,2,16220204
0,22.0,Hepatic fibrosis,2,16220258
1,22.0,Hepatitis acute,2,16220258
0,22.0,Renal cancer metastatic,5,16220266
1,22.0,Chronic respiratory failure,5,16220266
2,22.0,Chronic obstructive pulmonary disease,6,16220266
3,22.0,Malignant neoplasm progression,5,16220266
0,22.0,Abdominal pain,1,16220291
0,22.0,Eye excision,4,16220450
0,22.0,Circumstance or information capable of leading to medication error,6,16220725
1,22.0,Product dose omission,6,16220725
2,22.0,No adverse event,6,16220725
3,22.0,Product availability issue,6,16220725
0,22.0,Disease progression,6,16220819
1,22.0,Heart rate increased,6,16220819
0,22.0,Pneumonia,2,16220887
1,22.0,Neutropenic sepsis,1,16220887
2,22.0,Pancytopenia,1,16220887
0,22.0,Back pain,6,16220982
1,22.0,Blindness transient,6,16220982
2,22.0,Hot flush,6,16220982
3,22.0,Dizziness,6,16220982
0,22.0,Blood glucose increased,6,16221105
0,22.0,Depressed level of consciousness,3,16221111
1,22.0,Aphasia,3,16221111
2,22.0,Hemiplegia,3,16221111
0,22.0,Malignant neoplasm progression,5,16221163
1,22.0,Pneumococcal sepsis,6,16221163
2,22.0,Intentional product use issue,6,16221163
0,22.0,Altered state of consciousness,1,16221194
0,22.0,Drug ineffective,6,16221196
1,22.0,Disease progression,6,16221196
2,22.0,Death,5,16221196
0,22.0,Bladder cancer,3,16221238
1,22.0,Product supply issue,6,16221238
2,22.0,Product dose omission,6,16221238
0,22.0,Diarrhoea,3,16221245
1,22.0,Hypokalaemia,3,16221245
0,22.0,Alopecia,1,16221284
1,22.0,Stomatitis,1,16221284
2,22.0,Diarrhoea,1,16221284
3,22.0,Bone pain,3,16221284
4,22.0,Nausea,1,16221284
5,22.0,Myalgia,1,16221284
6,22.0,Peripheral sensory neuropathy,1,16221284
7,22.0,Urinary tract infection,1,16221284
8,22.0,Visual impairment,3,16221284
9,22.0,Dry skin,3,16221284
10,22.0,Chills,1,16221284
11,22.0,Erythema multiforme,1,16221284
12,22.0,Fatigue,3,16221284
13,22.0,Abscess,1,16221284
14,22.0,Diarrhoea,3,16221284
15,22.0,Rash pustular,1,16221284
16,22.0,Skin disorder,1,16221284
17,22.0,Epistaxis,1,16221284
0,22.0,Lymphadenopathy,3,16221305
1,22.0,Interstitial lung disease,6,16221305
2,22.0,Secondary adrenocortical insufficiency,6,16221305
3,22.0,Platelet count decreased,6,16221305
0,22.0,Product dispensing error,1,16221306
0,22.0,Prostate cancer metastatic,3,16221403
1,22.0,Therapeutic product effect decreased,6,16221403
0,22.0,Death,5,16221436
0,22.0,Alopecia,3,16221442
0,22.0,Deafness,3,16221454
1,22.0,Tympanic membrane disorder,3,16221454
2,22.0,Tinnitus,3,16221454
0,22.0,Metastases to spine,6,16221487
1,22.0,Metastases to pelvis,6,16221487
2,22.0,Breast cancer metastatic,6,16221487
3,22.0,Malignant neoplasm progression,6,16221487
0,22.0,Malignant neoplasm progression,5,16221563
0,22.0,Rash,6,16221579
0,22.0,Fatigue,3,16221588
1,22.0,Haemoglobin decreased,3,16221588
2,22.0,Incorrect dose administered,3,16221588
0,22.0,Hepatotoxicity,2,16221632
0,22.0,Toxicity to various agents,6,16221649
1,22.0,Off label use,1,16221649
2,22.0,Diarrhoea,1,16221649
3,22.0,Colitis,1,16221649
4,22.0,Confusional state,1,16221649
5,22.0,Fatigue,1,16221649
6,22.0,Malignant neoplasm progression,6,16221649
7,22.0,Pain,1,16221649
8,22.0,General physical health deterioration,1,16221649
9,22.0,Polyneuropathy,1,16221649
0,22.0,Leiomyoma,6,16221693
0,22.0,Death,5,16221697
0,22.0,Diarrhoea,6,16221721
1,22.0,Blood creatinine increased,6,16221721
2,22.0,Pyrexia,6,16221721
3,22.0,General physical condition decreased,6,16221721
0,22.0,Urinary tract infection,2,16221821
0,22.0,Osteonecrosis of jaw,3,16221865
0,22.0,Colorectal cancer metastatic,6,16221875
1,22.0,Skin reaction,6,16221875
0,22.0,Feeling hot,1,16221950
1,22.0,Dyspnoea,1,16221950
2,22.0,Oxygen saturation decreased,1,16221950
0,22.0,Neutropenia,3,16222027
1,22.0,Colitis,3,16222027
2,22.0,Hypoaesthesia,6,16222027
3,22.0,Folate deficiency,1,16222027
4,22.0,Rash pruritic,1,16222027
5,22.0,Palpitations,6,16222027
6,22.0,Mucosal inflammation,1,16222027
7,22.0,Dyspepsia,1,16222027
8,22.0,Thrombocytopenia,3,16222027
9,22.0,Pancytopenia,3,16222027
10,22.0,Dysphonia,2,16222027
11,22.0,Odynophagia,3,16222027
12,22.0,Pyrexia,1,16222027
13,22.0,Alopecia,3,16222027
14,22.0,Neuropathy peripheral,2,16222027
15,22.0,Throat irritation,3,16222027
16,22.0,Cough,1,16222027
17,22.0,Decreased appetite,3,16222027
18,22.0,Fatigue,1,16222027
19,22.0,Tremor,1,16222027
20,22.0,Lethargy,3,16222027
21,22.0,Diarrhoea,1,16222027
22,22.0,Weight decreased,3,16222027
0,22.0,Type 1 diabetes mellitus,2,16222052
1,22.0,Platelet count decreased,1,16222052
0,22.0,Death,5,16222125
1,22.0,Arthralgia,3,16222125
2,22.0,Gait disturbance,3,16222125
0,22.0,Electrocardiogram abnormal,3,16222195
0,22.0,Renal impairment,6,16222197
1,22.0,Weight decreased,6,16222197
0,22.0,Death,5,16222227
1,22.0,Blood sodium decreased,6,16222227
2,22.0,Blood iron decreased,6,16222227
0,22.0,Asthenia,6,16222233
1,22.0,Thrombophlebitis,6,16222233
2,22.0,Trigger finger,6,16222233
3,22.0,Pruritus,6,16222233
4,22.0,Diarrhoea,6,16222233
0,22.0,Anaemia,3,16222241
1,22.0,Neutropenia,3,16222241
2,22.0,Thrombocytopenia,3,16222241
0,22.0,Renal failure,3,16222242
0,22.0,Diarrhoea,1,16222245
1,22.0,Dyspnoea exertional,2,16222245
2,22.0,Hypertension,3,16222245
3,22.0,Hyperkalaemia,1,16222245
4,22.0,Hypercalcaemia,1,16222245
5,22.0,Nausea,1,16222245
0,22.0,Acute myocardial infarction,3,16222254
0,22.0,Nausea,3,16222255
1,22.0,Rash,3,16222255
2,22.0,Alopecia,3,16222255
3,22.0,Headache,3,16222255
4,22.0,Heart rate increased,6,16222255
5,22.0,Dry skin,6,16222255
6,22.0,Pulmonary embolism,6,16222255
7,22.0,Arthralgia,3,16222255
8,22.0,Fatigue,3,16222255
0,22.0,Product use in unapproved indication,6,16222284
1,22.0,Malignant neoplasm progression,5,16222284
0,22.0,Death,,16222285
0,22.0,Malaise,1,16222345
1,22.0,Product use in unapproved indication,6,16222345
2,22.0,Influenza like illness,1,16222345
3,22.0,Pyrexia,1,16222345
0,22.0,Left ventricular hypertrophy,6,16222376
1,22.0,Acute kidney injury,2,16222376
2,22.0,Sinus tachycardia,6,16222376
3,22.0,Diarrhoea,1,16222376
4,22.0,Lactic acidosis,1,16222376
0,22.0,Death,,16222407
0,22.0,Disease progression,,16222420
0,22.0,Hospitalisation,,16222425
0,22.0,Malaise,1,16222429
1,22.0,Diarrhoea,3,16222429
2,22.0,Chills,1,16222429
3,22.0,Nausea,1,16222429
4,22.0,Hypersensitivity,1,16222429
5,22.0,Vomiting,1,16222429
6,22.0,Depressed level of consciousness,1,16222429
7,22.0,Tremor,1,16222429
8,22.0,Nystagmus,1,16222429
9,22.0,Pyrexia,1,16222429
0,22.0,Drug resistance,6,16222431
1,22.0,Malignant neoplasm progression,6,16222431
2,22.0,Acquired gene mutation,6,16222431
0,22.0,Dehydration,2,16222437
1,22.0,Depression,6,16222437
0,22.0,Pulmonary alveolar haemorrhage,1,16222491
0,22.0,Disease progression,,16222510
0,22.0,Platelet count decreased,,16222527
1,22.0,Transfusion,,16222527
2,22.0,Red blood cell count decreased,,16222527
0,22.0,Skin infection,4,16222529
1,22.0,Pneumonia,5,16222529
2,22.0,Pyrexia,3,16222529
3,22.0,Malignant neoplasm progression,5,16222529
0,22.0,Wrong technique in product usage process,6,16222568
1,22.0,Product adhesion issue,6,16222568
0,22.0,Breast cancer metastatic,6,16222590
1,22.0,Malignant neoplasm progression,6,16222590
0,22.0,Bronchopulmonary aspergillosis,5,16222601
0,22.0,Vertigo,,16222615
1,22.0,Fatigue,,16222615
0,22.1,Pain in extremity,6,16222641
1,22.1,Incision site erythema,6,16222641
2,22.1,Mobility decreased,6,16222641
3,22.1,Nausea,1,16222641
4,22.1,White blood cell count decreased,6,16222641
5,22.1,Limb discomfort,6,16222641
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,,16222697
1,22.0,Blister,,16222697
2,22.0,Pain,,16222697
0,22.0,Therapy cessation,,16222719
1,22.0,Cardiomyopathy,,16222719
0,22.0,Death,,16222720
0,22.0,Gait disturbance,6,16222786
1,22.0,Mood altered,3,16222786
2,22.0,Paraesthesia,3,16222786
3,22.0,Fall,3,16222786
4,22.0,Prostatic specific antigen increased,6,16222786
5,22.0,Dementia,3,16222786
6,22.0,Osteoporosis,3,16222786
7,22.0,Hypoaesthesia,3,16222786
8,22.0,Constipation,3,16222786
9,22.0,Decreased appetite,3,16222786
10,22.0,Amnesia,3,16222786
11,22.0,Fatigue,3,16222786
12,22.0,Confusional state,6,16222786
13,22.0,Back pain,3,16222786
14,22.0,Bone pain,6,16222786
0,22.0,Muscle spasms,3,16222788
0,22.0,Hyperglycaemia,,16222803
1,22.0,Type 1 diabetes mellitus,,16222803
2,22.0,Immune system disorder,,16222803
3,22.0,Diabetic ketoacidosis,,16222803
0,22.0,Haemoptysis,6,16222819
1,22.0,Vomiting,6,16222819
0,22.0,Acute kidney injury,2,16222823
0,22.0,Liver disorder,1,16222825
1,22.0,Malaise,3,16222825
2,22.0,Faeces soft,6,16222825
3,22.0,White blood cell count decreased,6,16222825
4,22.0,Neutrophil count decreased,1,16222825
5,22.0,Blood creatinine increased,1,16222825
0,22.1,Alopecia,3,16222934
0,22.0,Anxiety,6,16222938
1,22.0,Alopecia,2,16222938
2,22.0,Emotional distress,6,16222938
3,22.0,Psychological trauma,6,16222938
4,22.0,Pain,6,16222938
5,22.0,Impaired quality of life,6,16222938
0,22.0,Anxiety,6,16222941
1,22.0,Impaired quality of life,6,16222941
2,22.0,Pain,6,16222941
3,22.0,Alopecia,3,16222941
4,22.0,Psychological trauma,6,16222941
5,22.0,Emotional distress,6,16222941
0,22.0,Psychological trauma,6,16222943
1,22.0,Alopecia,2,16222943
0,22.0,Psychological trauma,6,16222945
1,22.0,Alopecia,3,16222945
0,22.0,Alopecia,2,16222979
0,22.0,Alopecia,2,16222985
1,22.0,Emotional distress,6,16222985
2,22.0,Impaired quality of life,6,16222985
3,22.0,Anxiety,6,16222985
0,22.0,Gastrointestinal haemorrhage,6,16223164
0,22.0,Death,,16223193
0,22.0,T-lymphocyte count increased,6,16223241
0,22.0,Dyspnoea,6,16223242
0,22.0,White blood cell count decreased,6,16223275
0,22.1,Dyspepsia,6,16223281
1,22.1,Feeling abnormal,6,16223281
2,22.1,Bone pain,6,16223281
3,22.1,Toothache,6,16223281
4,22.1,Arthropathy,6,16223281
5,22.1,Bone lesion,6,16223281
0,22.0,Renal disorder,1,16223327
1,22.0,Fatigue,6,16223327
2,22.0,Swelling,6,16223327
3,22.0,Somnolence,3,16223327
4,22.0,Dysgeusia,6,16223327
0,22.0,Drug ineffective,6,16223338
1,22.0,Myopathy,6,16223338
2,22.0,Pneumonitis,1,16223338
3,22.0,Cushingoid,6,16223338
4,22.0,Fatigue,6,16223338
5,22.0,Transaminases increased,6,16223338
6,22.0,Oedema,6,16223338
0,22.0,Nausea,6,16223340
1,22.0,Neurotoxicity,1,16223340
2,22.0,Fatigue,6,16223340
3,22.0,Cerebellar syndrome,1,16223340
0,22.0,Anaemia,2,16223391
1,22.0,Thrombocytopenia,2,16223391
0,22.0,Fall,6,16223393
1,22.0,Fracture,1,16223393
0,22.0,Anaemia,2,16223396
1,22.0,Malignant neoplasm progression,6,16223396
2,22.0,Nausea,6,16223396
3,22.0,Product prescribing error,6,16223396
4,22.0,Intussusception,1,16223396
5,22.0,Decreased appetite,6,16223396
0,22.0,Enteritis,2,16223415
1,22.0,Constipation,6,16223415
2,22.0,Colitis,2,16223415
0,22.0,Alopecia,2,16223428
0,22.0,Metastases to central nervous system,3,16223469
1,22.0,Asthenia,6,16223469
2,22.0,Hepatic enzyme increased,6,16223469
0,22.0,Product use in unapproved indication,6,16223473
1,22.0,General physical health deterioration,6,16223473
2,22.0,Off label use,6,16223473
0,22.0,Therapy cessation,,16223591
1,22.0,Gastric ulcer,,16223591
0,22.0,Therapeutic product effect incomplete,6,16223596
0,22.0,Burning sensation,3,16223632
0,22.0,General physical health deterioration,6,16223674
0,22.0,Clostridium colitis,5,16223677
1,22.0,Chronic obstructive pulmonary disease,3,16223677
2,22.0,Septic shock,5,16223677
3,22.0,Hypercapnia,3,16223677
4,22.0,Acute kidney injury,3,16223677
5,22.0,Respiratory failure,3,16223677
6,22.0,Coronary artery disease,5,16223677
7,22.0,Drug ineffective,6,16223677
0,22.0,Dysphagia,6,16223700
0,22.0,Pulmonary thrombosis,6,16223718
0,22.0,Vomiting,1,16223728
1,22.0,Confusional state,1,16223728
2,22.0,Balance disorder,1,16223728
3,22.0,Nausea,1,16223728
0,22.0,Adverse event,6,16223730
1,22.0,Adverse event,6,16223730
2,22.0,Adverse event,6,16223730
3,22.0,Adverse event,6,16223730
4,22.0,Adverse event,6,16223730
5,22.0,Adverse event,6,16223730
6,22.0,Adverse event,6,16223730
7,22.0,Product use in unapproved indication,6,16223730
0,22.0,Death,5,16223747
0,22.0,Dizziness,2,16223842
1,22.0,Malaise,6,16223842
2,22.0,Neoplasm progression,6,16223842
3,22.0,Product dose omission,6,16223842
4,22.0,Asthenia,2,16223842
0,22.0,Respiratory tract infection,1,16223850
1,22.0,Anaemia,1,16223850
2,22.0,Diarrhoea,1,16223850
3,22.0,Dysgeusia,3,16223850
0,22.0,Hyponatraemia,1,16223865
1,22.0,Febrile neutropenia,1,16223865
2,22.0,Dehydration,1,16223865
3,22.0,Diarrhoea,1,16223865
4,22.0,Hypokalaemia,1,16223865
0,22.0,Lower respiratory tract infection,1,16223883
0,22.0,Eosinophilia,3,16223923
1,22.0,Purpura,3,16223923
2,22.0,Hallucination,1,16223923
3,22.0,Pruritus,3,16223923
4,22.0,Confusional state,1,16223923
5,22.0,Oedema,3,16223923
0,22.0,Renal impairment,6,16223964
1,22.0,Dry mouth,6,16223964
2,22.0,Blood pressure increased,3,16223964
3,22.0,Dehydration,6,16223964
4,22.0,Fatigue,6,16223964
5,22.0,Oropharyngeal pain,6,16223964
6,22.0,Dizziness,6,16223964
7,22.0,Constipation,3,16223964
8,22.0,Intestinal obstruction,6,16223964
9,22.0,Diarrhoea,6,16223964
0,22.0,Vomiting,6,16224005
1,22.0,Fatigue,6,16224005
2,22.0,Hypersomnia,6,16224005
3,22.0,Death,5,16224005
4,22.0,Decreased appetite,6,16224005
5,22.0,Intentional product misuse,6,16224005
0,22.0,Adverse event,6,16224237
1,22.0,Product use in unapproved indication,6,16224237
0,22.0,Death,5,16224324
1,22.0,Off label use,6,16224324
0,22.0,Neurotoxicity,1,16224330
0,22.1,Pyrexia,3,16224346
1,22.1,Constipation,3,16224346
2,22.1,Fatigue,3,16224346
3,22.1,Oral pain,1,16224346
4,22.1,Bone pain,6,16224346
5,22.1,Hypoaesthesia,3,16224346
6,22.1,Asthenia,6,16224346
7,22.1,Infection,6,16224346
8,22.1,Pyrexia,1,16224346
9,22.1,Diarrhoea,3,16224346
10,22.1,Immune system disorder,6,16224346
11,22.1,Urinary tract infection,3,16224346
12,22.1,Musculoskeletal stiffness,3,16224346
13,22.1,Vomiting,1,16224346
14,22.1,Abdominal pain,1,16224346
15,22.1,Abdominal pain,1,16224346
16,22.1,Sepsis,6,16224346
17,22.1,Dehydration,3,16224346
18,22.1,Decreased appetite,1,16224346
19,22.1,Nausea,3,16224346
20,22.1,Arthralgia,3,16224346
21,22.1,Alopecia,3,16224346
22,22.1,Gastrointestinal pain,3,16224346
23,22.1,Visual impairment,3,16224346
24,22.1,Stomatitis,6,16224346
25,22.1,Kidney infection,3,16224346
26,22.1,Respiratory tract infection,6,16224346
27,22.1,Hot flush,3,16224346
28,22.1,Neoplasm progression,6,16224346
0,22.0,Bone pain,6,16224371
1,22.0,Arthralgia,6,16224371
0,22.0,Pneumonia,1,16224409
1,22.0,Pulmonary fibrosis,4,16224409
0,22.0,Enterocolitis,1,16224775
0,22.1,Pneumonitis,5,16224780
